Skip to main content
Top
Published in: Clinical and Translational Oncology 5/2010

01-05-2010 | Editorial

Treatment of localised prostate cancer with radiation therapy: evidence versus opinion

Authors: Ferran Guedea, Alfredo Ramos, Ismael Herruzo, José Antonio Sánchez Calzado, Jorge Contreras, Jesús Romero, Jordi Craven-Bartle, Patricia Willisch, José Luis López Torrecilla, Xavier Maldonado, Gemma Sancho, Almudena Zapatero, Montserrat Ferrer, Yolanda Pardo, Pablo Fernández, Alfonso Mariño, Asunción Hervás, Víctor Macías, Ana Boladeras, Ferran Ferrer, Brian J. Davis, on behalf of SEOR (Spanish Society of Radiation Oncology), on behalf of UROONCOR (Prostate Group of SEOR), members of the Multicentric Spanish Group of Clinically Localized Prostate Cancer

Published in: Clinical and Translational Oncology | Issue 5/2010

Login to get access
Metadata
Title
Treatment of localised prostate cancer with radiation therapy: evidence versus opinion
Authors
Ferran Guedea
Alfredo Ramos
Ismael Herruzo
José Antonio Sánchez Calzado
Jorge Contreras
Jesús Romero
Jordi Craven-Bartle
Patricia Willisch
José Luis López Torrecilla
Xavier Maldonado
Gemma Sancho
Almudena Zapatero
Montserrat Ferrer
Yolanda Pardo
Pablo Fernández
Alfonso Mariño
Asunción Hervás
Víctor Macías
Ana Boladeras
Ferran Ferrer
Brian J. Davis
on behalf of SEOR (Spanish Society of Radiation Oncology)
on behalf of UROONCOR (Prostate Group of SEOR)
members of the Multicentric Spanish Group of Clinically Localized Prostate Cancer
Publication date
01-05-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-010-0511-y

Other articles of this Issue 5/2010

Clinical and Translational Oncology 5/2010 Go to the issue

News and Views

A Law for Science

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine